Treating Solid Organ Diseases with Innovative Chimeric-Antigen Receptor T-cells: Current indications, progress, limitations and potential strategies

Articles

EDITORIAL

Published on 24 Sep 2024

Editorial: Treating solid organ diseases with innovative chimeric-antigen receptor T-cells: current indications, progress, limitations and potential strategies

SYSTEMATIC REVIEW

Published on 10 May 2024

The synergistic immunotherapeutic impact of engineered CAR-T cells with PD-1 blockade in lymphomas and solid tumors: a systematic review

ORIGINAL RESEARCH

Published on 18 Mar 2024

Universal CAR T cells targeted to HER2 with a biotin-trastuzumab soluble linker penetrate spheroids and large tumor xenografts that are inherently resistant to trastuzumab mediated ADCC

ORIGINAL RESEARCH

Published on 14 Mar 2024

Low-dose targeted radionuclide therapy synergizes with CAR T cells and enhances tumor response

MINI REVIEW

Published on 22 Feb 2024

Recent advances on CAR-T signaling pave the way for prolonged persistence and new modalities in clinic

REVIEW

Published on 31 Oct 2022

Chimeric antigen receptor T cells applied to solid tumors

Share on

Frontiers in Immunology

Submit your idea